Manon Brilland-De Vries

Angers, 49055, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A Rare Case of Metastatic Urethral Squamous Cell Carcinoma Presenting with Paraneoplastic Sweet Syndrome and Treated with Pembrolizumab.

A Rare Case of Metastatic Urethral Squamous Cell Carcinoma Presenting with Paraneoplastic Sweet Syndrome and Treated with Pembrolizumab.

Journal: Current oncology (Toronto, Ont.)

Published: October 28, 2025

Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.

Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.

Journal: The oncologist

Published: May 23, 2025

Learning to Train and to Explain a Deep Survival Model with Large-Scale Ovarian Cancer Transcriptomic Data.

Learning to Train and to Explain a Deep Survival Model with Large-Scale Ovarian Cancer Transcriptomic Data.

Journal: Biomedicines

Published: November 25, 2024

PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort.

PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 05, 2024

Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study.

Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study.

Journal: European urology oncology

Published: January 05, 2024

Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.

Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: October 19, 2023

Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.

Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 16, 2023

Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study).

Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study).

Journal: The oncologist

Published: March 15, 2021

Checkpoint inhibitors in metastatic papillary renal cell carcinoma.

Checkpoint inhibitors in metastatic papillary renal cell carcinoma.

Journal: Cancer treatment reviews

Published: March 11, 2021

Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study.

Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 10, 2019

Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the Literature.

Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the Literature.

Journal: Clinical genitourinary cancer

Published: February 09, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026